Our study found that Black patients diagnosed with TNBC and ERBB2+ breast cancer had more refractory disease to NACT, whereas those of other races and ethnicities, especially Asian patients, had more sensitive disease. The gene discussed is ERBB2; the disease is breast carcinoma.